Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications
Gene Therapy in a Humanized Mouse Model of Familial Hypercholesterolemia Leads to Marked Regression of Atherosclerosis | PLOS ONE
Atherosclerosis and Cardiovascular Disease - Life Extension
The tandem stenosis mouse model: Towards understanding, imaging, and preventing atherosclerotic plaque instability and rupture - Noonan - 2022 - British Journal of Pharmacology - Wiley Online Library
Atherosclerotic Plaque Destabilization in Mice: A Comparative Study | PLOS ONE
Mechanisms underlying the therapeutic potential of mesenchymal stem cells in atherosclerosis | Regenerative Medicine
Endometriosis promotes atherosclerosis in a murine model
PDF) Göttingen minipig model of diet-induced atherosclerosis: Influence of mild streptozotocin-induced diabetes on lesion severity and markers of inflammation evaluated in obese, obese and diabetic, and lean control animals
Mouse models of atherosclerosis in translational research: Trends in Pharmacological Sciences
Small rodent models of atherosclerosis - ScienceDirect
Mouse models of atherosclerosis and their suitability for the study of myocardial infarction | SpringerLink
Migratory and Dancing Macrophage Subsets in Atherosclerotic Lesions | Circulation Research
Small rodent models of atherosclerosis - ScienceDirect
Vascular Macrophages in Atherosclerosis
Role of smooth muscle cells in Cardiovascular Disease
The cellular biology of atherosclerosis with atherosclerotic lesion classification and biomarkers | Bulletin of the National Research Centre | Full Text
The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways | JACC: Basic to Translational Science
Animal models of atherosclerosis - ScienceDirect
Modeling early stage atherosclerosis in a primary human vascular microphysiological system | Nature Communications
Research methods for animal models of atherosclerosis (Review)
Immune cell profiling in atherosclerosis: role in research and precision medicine | Nature Reviews Cardiology
![Thieno[2,3-c]Isoquinolin-5-one, a Potent Poly(ADP-Ribose) Polymerase Inhibitor, Promotes Atherosclerotic Plaque Regression in High-Fat Diet-Fed Apolipoprotein E-Deficient Mice: Effects on Inflammatory Markers and Lipid Content | Journal of Pharmacology ...](https://jpet.aspetjournals.org/content/jpet/329/1/150/F1.large.jpg "Thieno[2,3-c]Isoquinolin-5-one, a Potent Poly(ADP-Ribose) Polymerase Inhibitor, Promotes Atherosclerotic Plaque Regression in High-Fat Diet-Fed Apolipoprotein E-Deficient Mice: Effects on Inflammatory Markers and Lipid Content | Journal of Pharmacology ...")
Thieno[2,3-c]Isoquinolin-5-one, a Potent Poly(ADP-Ribose) Polymerase Inhibitor, Promotes Atherosclerotic Plaque Regression in High-Fat Diet-Fed Apolipoprotein E-Deficient Mice: Effects on Inflammatory Markers and Lipid Content | Journal of Pharmacology ...
